There is still much controversy about the precursor cell type in multiple myeloma (MM). Some authors claim that it is a pre‐B cell, others state that it is a memory B cell or plasmablast. We have recently shown that the VDJ region of the MM immunoglobulin heavy chain gene is somatically hypermutated and antigen selected, without intraclonal variation or evolution in time. By using a patient‐specific PCR approach we have now obtained evidence that the premyeloma cell can be situated in the pre‐switched B‐cell compartment and that heavy chain switching can occur without further somatic mutation. Based on the MM immunoglobulin sequences derived from the bone marrow, patient‐specific CDR2 and CDR3 oligonucleotides were designed. B lymphocytes were separated from plasma cells based on the expression of CD19 and HLA class II or surface bound IgM using immunomagnetic beads. The expressed Ig sequences were amplified by RT‐PCR using patient specific CDR2 primers and isotype specific primers (Cμ, Cγ and Cα). Myeloma‐specific Ig sequences were detected by a myeloma‐specific CDR 3 probe and sequenced. In one out of five cases we found in the peripheral blood clonally related IgM and IgA sequences with the same somatic mutations as the MM‐IgG sequence. In another case of an IgG MM we found in the bone marrow clonally related IgA sequences with the same somatic mutations. These findings, together with the fact that myeloma‐Ig genes contain somatic mutations without intraclonal variation, suggest that the clonogenic cell in multiple myeloma can originate from a pre‐switched but somatically mutated B cell.